Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

15 trials with published results (18%)

Research Maturity

57 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.1%

5 terminated out of 82 trials

Success Rate

91.9%

+5.4% vs benchmark

Late-Stage Pipeline

22%

18 trials in Phase 3/4

Results Transparency

26%

15 of 57 completed with results

Key Signals

15 with results92% success

Data Visualizations

Phase Distribution

61Total
Not Applicable (34)
P 1 (3)
P 2 (6)
P 3 (11)
P 4 (7)

Trial Status

Completed57
Recruiting7
Unknown5
Not Yet Recruiting5
Terminated5
Active Not Recruiting2

Trial Success Rate

91.9%

Benchmark: 86.5%

Based on 57 completed trials

Clinical Trials (82)

Showing 20 of 20 trials
NCT06428643Not ApplicableRecruiting

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

NCT06766331Not ApplicableNot Yet Recruiting

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

NCT07516912Not Yet Recruiting

Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland

NCT07500415Not ApplicableRecruiting

Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro

NCT05766904Phase 3Active Not RecruitingPrimary

Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections

NCT07464236Not ApplicableNot Yet Recruiting

Improving Clinic Delivery of HIV-related Anal Health Services

NCT06187064Not ApplicableCompleted

Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

NCT04966507Phase 2CompletedPrimary

Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention

NCT07397403Phase 4Recruiting

The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.

NCT06738407Phase 4Not Yet RecruitingPrimary

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

NCT05723263Not ApplicableCompletedPrimary

Pay-it-forward Gonorrhea and Chlamydia Testing Among Men in China

NCT03715335Not ApplicableCompletedPrimary

Adolescent Sexually Transmitted Infection Screening in the Emergency Department

NCT03959527Phase 3CompletedPrimary

Zoliflodacin in Uncomplicated Gonorrhoea

NCT05541081Not ApplicableCompleted

Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in Zimbabwe

NCT06154239Not ApplicableCompleted

Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views

NCT06446752Phase 3Active Not RecruitingPrimary

BIYELA - Bexsero Immunisation in Young Women in Africa

NCT06100250Not ApplicableCompleted

Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening

NCT06951438Not ApplicableRecruiting

Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

NCT05873751CompletedPrimary

A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

NCT06188442Phase 4Recruiting

Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM

Scroll to load more

Research Network

Activity Timeline